Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Varian Medical Systems Inc Issues Q1 2013 Guidance; Q1 2013 Revenue Guidance Above Analysts' Estimates; Issues FY 2013 Guidance In Line With Analysts' Estimates


Thursday, 25 Oct 2012 04:01pm EDT 

Varian Medical Systems Inc announced that for fiscal 2013, it expects revenue to increase by 8% to 9% over fiscal 2012. net earnings per diluted share should be in the range of $4.06 to $4.16. For the first quarter of 2013, total company revenues could increase by about 8% to 9% over the prior year quarter. Net earnings per diluted share, including the planned restructuring charge of $0.02 to $0.03, should be in the range of $0.83 to $0.88. The Company reported revenues of $2.807 billion in fiscal 2012 and revenues of $625 million in the first quarter of 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $3.030 billion and EPS of $4.11 for fiscal 2013; revenues of $672 million and EPS of $0.86 for the first quarter of 2013. 

Company Quote

85.14
-0.12 -0.14%
11 Jul 2014